Adopting the advice of its Advisory Committee on Immunization Practices, the Centers for Disease Control and Prevention last night recommended the Pfizer-BioNTech vaccine for children aged 12 to 15, paving the way for providers to begin vaccinating them immediately. The Food and Drug administration Monday authorized emergency use of the vaccine in this age group. 

“I encourage parents with questions to talk to your child’s healthcare provider or your family doctor to learn more about the vaccine,” said CDC Director Rochelle Walensky, M.D. “And if your adolescent is behind on routinely recommended vaccines due to the pandemic or for other reasons, now would be a good time to work with your child’s nurse or doctor to make sure they get caught up.”

CDC tomorrow will host a call for clinicians on the recommendations and clinical guidance for using the Pfizer-BioNTech vaccine in this age group. The agency plans to post a recording a few hours after the 2 p.m. ET call for those unable to attend. 
 

FDA previously authorized the vaccine for Americans aged 16 and older.

Related News Articles

Headline
Pfizer has submitted a request for the Food and Drug Administration to authorize a 10-microgram booster dose of its bivalent COVID-19 vaccine booster for…
Headline
Health care providers who treat uninsured or underinsured patients with commercially procured bebtelovimab, a COVID-19 monoclonal antibody therapy for…
Headline
Moderna Friday submitted its request that the Food and Drug Administration authorize for emergency use its bivalent COVID-19 vaccine for children and…
Headline
The Centers for Disease Control and Prevention Friday updated its COVID-19 infection control guidance for U.S. health care settings based on current…
Headline
AHA will co-host a Sept. 27 Facebook Live event with AdventHealth on the importance of getting children vaccinated and boosted against COVID-19, which will…
Headline
Insured and uninsured Americans can receive the new bivalent Pfizer or Moderna COVID-19 booster and other COVID-19 vaccines at no cost as long as the federal…